Insperity heads into its July 29 earnings print with options traders at their most defensive in at least a year — and for good reason, given what happened last time.
The options signal is the sharpest thing in the data right now. The put/call ratio has jumped to 2.71, nearly three standard deviations above its 20-day average of 1.53. That z-score of 2.94 is essentially at the 52-week high for the ratio, which peaked at 2.72 just the day before. The shift is abrupt: through most of June and early July the PCR ran between 1.30 and 1.50, then lurched sharply higher in the past two sessions. Options traders are not hedging cautiously — they are piling into puts at an unusual rate, and the timing relative to the July 29 report is hard to ignore.
The lending market tells a much calmer story, and that contrast is worth naming. Short interest has edged down roughly 1.5% on the week to 11.3% of the free float — elevated in absolute terms but grinding lower rather than building. Borrow costs are almost negligible at 0.55%, up fractionally on the week but well below levels seen in June. Availability is loose at 443%, meaning the lending pool holds more than four times the shares currently borrowed. Short sellers are not aggressively pressing into the print. The ORTEX short score holds steady near 60, in the middle of its recent range. What the positioning data says collectively is this: bears are expressing their view through puts, not through short selling.
The Street is sending a mixed message, though the most recent move is notable. Truist Securities raised its price target from $35 to $52 today — matching almost exactly where the stock trades at $51.11 — while keeping a Hold rating. That's a dramatic revision from a firm that spent much of 2025 cutting its target repeatedly, all the way down from $95 in late 2024. JP Morgan remains Underweight with a $33 target, implying meaningful downside from current levels. The consensus sits at Hold with a mean target of $39.50, which is well below the current price — a gap that flags caution on valuation even after the sharp recent rally. The PE multiple has expanded to 20.7x, up more than six points over the past month, as the stock has climbed 41% in that window. Bulls point to the Workday partnership and steady demand from small and midsize businesses for outsourced HR. Bears cite healthcare cost inflation eating into margins and sluggish workforce growth among existing clients.
The CEO has been buying aggressively. Paul Sarvadi accumulated shares across multiple tranches from mid-March through early June — roughly 535,000 shares in total, at prices ranging from $22.53 to $34.05, for a combined outlay of around $15.75 million in the 90-day window. That cluster of purchases, concentrated at prices well below where the stock now trades, is one reason the institutional ownership picture remains dense: BlackRock holds nearly 14% of shares, Reinhart Partners added 356,000 shares in Q2, and Hawk Ridge Capital built a new position of 1.46 million shares as of March. Sarvadi's own stake now accounts for roughly 4.6% of the company.
The earnings history is the starkest data point of all. The last print, on April 30, sent the stock down 23% the next day and another 12% over the following week. That reaction came after the company missed estimates and guided down, with healthcare benefit costs the primary culprit. NSP has since recovered all of that ground and more — the 41% one-month rally prices in a meaningful improvement in the underlying business. Peers have also moved: Robert Half is up 15% on the week and ManpowerGroup has surged 32%, suggesting broad sector tailwinds from a stabilising labour market. TriNet and Barrett Business Services are up roughly 5% and 3% respectively. NSP's 7.6% weekly gain is solid but more measured than the outliers, which may reflect the specific overhang around its healthcare cost profile heading into the July 29 release.
Whether the put activity is covering residual fear from April or pricing in fresh downside risk is the question the July 29 print will answer.
See the live data behind this article on ORTEX.
Open NSP on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
